-
L-Proline benzyl ester hydrochloride 16652-71-4
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |L-Proline benzyl ester hydrochloride |CAS: 16652-71-4 |C12H15NO2.HCl
-
(S)-1-Boc-3-hydroxypiperidine 143900-44-1
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Ise elegbogi |Antitumor oloro |Ibrutinib Intermediates |(S) -1-Boc-3-hydroxypiperidine |CAS: 143900-44-1 |C10H19NO3
-
Duloxetine hydrochloride 136434-34-9
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹkọ-ara |Ibanujẹ |Duloxetine hydrochloride |CAS: 136434-34-9 |C18H19NOS.HCl;C18H20ClNOS
-
(S)-(-) N, N-Dimethyl-3-hydroxy-3- (2-thienyl) propanamine 132335-44-5
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹkọ-ara |Ibanujẹ |Duloxetine Intermediates |(S)-(-) N, N-Dimethyl-3-hydroxy-3- (2-thienyl) propanamine |CAS: 132335-44-5 |C9H15NOS
-
(S)-3-(Methylamino)-1- (thiophen-2-yl) propan-1-ol 116539-55-0
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Kemikali Reagents |Kemikali aise ohun elo |Ise elegbogi agbedemeji |Ẹkọ-ara |Ibanujẹ |Duloxetine Intermediates |(S) -3- (Methylamino) -1- (thiophen-2-yl) propan-1-ol |CAS: 116539-55-0 |C8H13NOS
-
2-Chloro-L-phenylalanine 103616-89-3
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |2-Chloro-L-phenylalanine |CAS: 103616-89-3 |C9H10ClNO2
-
2-Chloro-D-phenylalanine 80126-50-7
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |2-Chloro-D-phenylalanine |CAS: 80126-50-7 |C9H10ClNO2
-
3-Bromo-D-phenylalanine 99295-78-0
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |3-Bromo-D-phenylalanine |CAS: 99295-78-0 |C9H10BrNO2
-
(R) -tert-butyl 3-amino-4-oxo-4-(((R)-1-phenylethyl)amino)butanoate 512785-16-9
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |(R) -tert-butyl 3-amino-4-oxo-4-(((R) 1 phenylethyl)amino) butanoate |CAS: 512785-16-9 |C16H24N2O3
-
Boc-D-Aspartic acid 62396-48-9
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |Boc-D-Aspartic acid |CAS: 62396-48-9 |C9H15NO6
-
Fmoc-N'-Acetyl-L-lysine 159766-56-0
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |Amino acid jara |Fmoc-N'-Acetyl-L-lysine |CAS: 159766-56-0 |C23H26N2O5
-
N-Fmoc-7-methyl-L-tryptophan 1808268-53-2
Ọjọgbọn ẹrọ ati ipese biopharmaceutical |Awọn ohun elo aise |Pharmaceutical Intermediates Reagents |Imuniloji |Peptide kolaginni |N-Fmoc-7-methyl-L-tryptophan |CAS: 1808268-53-2 |C27H24N2O4